(VIANEWS) – Shares of Pacific Biosciences of California (NASDAQ Composite: PACB) dropped 7.05% to $25.58 at 00:36 EST on Monday, after two sequential sessions in a row of losses. NASDAQ Composite is rising 1.02% to $14,896.85, after five successive sessions in a row of losses. This seems, as yet, an all-around bullish trend exchanging session today.

Pacific Biosciences of California’s last close was $31.23, 41.83% below its 52-week high of $53.69.

Volume

Today’s last reported volume for Pacific Biosciences of California is 1838362 which is 1.96% below its average volume of 1875150.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 63.1% for the present quarter and 39.6% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 50% and a negative 164.9%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 92.29M for the twelve trailing months.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $25.58 at 00:36 EST, way below its 52-week high of $53.69 and way higher than its 52-week low of $8.05.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s value is way under its 50-day moving average of $29.68 and way below its 200-day moving average of $29.90.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here